)
Accendra Health (ACH) investor relations material
Accendra Health Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q1 2026 results aligned with expectations, marking the first full quarter as a standalone home-based care company after separation from Owens & Minor, with transition services and separation activities progressing on schedule.
Achieved Q1 2026 net revenue of $628M, down from $674M in Q1 2025, reflecting the impact of a terminated large commercial payor contract and changes in collection rates and volume growth.
Substantial completion of exit from a large commercial payer, with a smooth handover and minimized transition costs.
Announced a $1.5 billion balance sheet optimization transaction with creditor commitments to strengthen liquidity, extend maturities, and reduce leverage.
Strategic initiatives in sleep therapy and operational streamlining are driving growth and efficiency.
Financial highlights
Net revenue for Q1 2026 was $627.8 million, down from $673.9 million in Q1 2025, with revenue down 6.8% year-over-year but up 1% excluding a major payer exit.
Adjusted EBITDA for Q1 2026 was $58 million, down from $96 million in Q1 2025, in line with expectations.
Free cash flow for Q1 2026 was negative $2 million, reflecting typical seasonal softness and significant one-time items.
Extraordinary payments included $19 million to the IRS and $22 million in legal and advisory fees for the P&HS divestiture.
Net debt remained flat at $1.77 billion; $337 million in cash and $195 million available under the revolving credit facility.
Outlook and guidance
Affirmed 2026 outlook for revenue and adjusted EBITDA, with expectations for greater revenue growth and at least 65% of adjusted EBITDA in Q3 and Q4.
FY26E Adjusted EBITDA (minus patient service equipment capex) projected at $218M, supporting operating stability and growth investments.
Annualized cash interest expense expected to increase by about $40 million due to refinancing, with half impacting the second half of 2026.
Sustained free cash flow profile expected to provide liquidity and strategic flexibility.
Outlook based on assumptions regarding market conditions, consumer demand, supply chain stability, and interest rates.
- Virtual annual meeting to vote on directors, auditor, compensation, and incentive plan.ACH
Proxy filing2 Apr 2026 - Shareholders to vote on directors, auditor, executive pay, and expanded equity plan amid strategic transformation.ACH
Proxy filing2 Apr 2026 - 2026 guidance projects $2.55–$2.65B revenue, $335–$355M EBITDA, and strong cash flow.ACH
Q4 202519 Feb 2026 - $1.36B Rotech deal expands Patient Direct, targets $5B revenue, $50M synergies by year three.ACH
M&A Announcement3 Feb 2026 - Q2 revenue up 4–4.2% to $2.67–$2.7B; Rotech deal announced; 2024 outlook reaffirmed.ACH
Q2 20242 Feb 2026 - Q3 revenue up 5% to $2.7B, driven by Patient Direct and $198M debt reduction.ACH
Q3 202417 Jan 2026 - Proxy covers director elections, auditor ratification, say-on-pay, and strong ESG focus.ACH
Proxy Filing1 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay; online access promoted.ACH
Proxy Filing1 Dec 2025 - 2024 delivered higher revenue, major debt reduction, and a strong 2025 growth outlook.ACH
Q4 20241 Dec 2025
Next Accendra Health earnings date
Next Accendra Health earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)